SSCI and Whitehouse Laboratories, divisions of Albany Molecular Research, Inc, are looking forward to exhibiting at the INTERPHEX 2017! Sponsored by the Parenteral Drug Association (PDA), the New York Interphex Show will open on March 21 and run through March 23. With over 12,000 industry professionals in attendance and more than 625 exhibitors, the educational and networking opportunities are extremely valuable. INTERPHEX is viewed as the key show for all of the latest information on new products, technologies and other key developments surrounding the bio pharmaceutical industry.
“We look forward to attending this invaluable conference as we are on the cutting edge of trends and issues relating to pharmaceutical analysis,” commented Dr. Pamela Smith, Vice President, Global Analytical Services at Albany Molecular Research, Inc. “As the leading expert in solid state and analytical chemistry services, attending Interphex provides us an opportunity to share insights into best practices for preformulation, material science, particle engineering, and analytical testing services of small and large molecules. In addition, we compliment our analytical capabilities with medical device and drug delivery testing, package and distribution testing.”